Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from ...

GSK plc has announced the acquisition of American Depositary Shares (ADSs) by two of its executives, Dr. Hal Barron and James Ford, through reinvestment of dividends in their respective savings plans.

In conclusion, GlaxoSmithKline's shares showed significant gains today, reflecting positive market sentiment and strong ...

GlaxoSmithKline and Vir finally score $1B supply deal for COVID antibody—6 months after FDA nod Continued emergence of omicron could spark a rush of sales for GSK-Vir's antibody therapy.

CARLISLE - GlaxoSmithKline, one of the world’s largest pharmaceutical companies, confirmed Monday that it will close a manufacturing facility in Carlisle next year. Production in Carlisle will ...

GlaxoSmithKline, which is based in London, was formed on Jan. 1, 2001 by the $76 billion merger of Glaxo Wellcome, the maker of Wellbutrin (depression) and Imitrex (migraines), and SmithKline ...

GlaxoSmithKline is further building out its cancer drug portfolio by acquiring Sierra Oncology, a biotech whose FDA-ready myelofibrosis drug has clinical data showing advantages over a blockbuster ...

GlaxoSmithKline, under activist pressure, gets some relief as Elliott won't push for sale or slash R&D: report By Fraiser Kansteiner May 27, 2021 9:29am ...

U.K.-based pharmaceutical giant GlaxoSmithKline currently sits nearly 50% off the all-time highs it set way back in 1999. Over its 300 year history , the company has been behind some of the most ...

Photo by Flickr user Ian Wilson Doctors will no longer be paid to speak on behalf of GlaxoSmithKline and its products, the British drug maker said Tuesday. In addition, the pharmaceutical company ...

Drug maker GlaxoSmithKline said it will lay off hundreds of its U.S. workers to reduce costs and to streamline its research and drug-marketing operations by the end of 2015.

GlaxoSmithKline’s (GSK) materially understated profits and alarming and material disclosures in the 10-Ks of Squarespace (SQSP), VBI Vaccines (VBIV), and Research Frontiers (REFR).